Reading Immanence

The following text opened the conference, “The Concept of Immanence in Philosophy and the Arts”, held in Vienna in May 2016. It is a reader consisting of key passages on immanence by Gilles Deleuze, Baruch de Spinoza, Giorgio Agamben, Henri Bergson, François Laruelle, Antonin Artaud and Friedrich Nietzsche. The reader was put together by Arno Böhler and Elisabeth Schäfer, and a collage of its content arranged by Susanne Valerie Granzer, who read out these text fragments at the start of the conference. Her reading was sporadically interrupted by Alice Lagaay, whose comments served to draw lines of connection between the dense theoretical texts and the performative immanent context in which they were being read and digested—the context of the conference. We present here the readings and their lighthearted—and at times deadly serious—commentary as performed. Readers are invited to imagine and re-enact the live-ness of this event, letting their own comments, questions and musings interrupt the proposed interruptions of reading

Reading Immanence

The following text opened the conference, “The Concept of Immanence in Philosophy and the Arts”, held in Vienna in May 2016. It is a reader consisting of key passages on immanence by Gilles Deleuze, Baruch de Spinoza, Giorgio Agamben, Henri Bergson, François Laruelle, Antonin Artaud and Friedrich Nietzsche. The reader was put together by Arno Böhler and Elisabeth Schäfer, and a collage of its content arranged by Susanne Valerie Granzer, who read out these text fragments at the start of the conference. Her reading was sporadically interrupted by Alice Lagaay, whose comments served to draw lines of connection between the dense theoretical texts and the performative immanent context in which they were being read and digested—the context of the conference. We present here the readings and their lighthearted—and at times deadly serious—commentary as performed. Readers are invited to imagine and re-enact the live-ness of this event, letting their own comments, questions and musings interrupt the proposed interruptions of reading

A Prospective Study of Pravastatin in the Elderly at Risk (PROSPER): Screening Experience and Baseline Characteristics

BACKGROUND: PROSPER was designed to investigate the benefits of treatment with pravastatin in elderly patients for whom a typical doctor might consider the prescription of statin therapy to be a realistic option. METHODS: The PROspective Study of Pravastatin in the Elderly at Risk (PROSPER) is a randomised, double blind, placebo-controlled trial to test the hypothesis that treatment with pravastatin (40 mg/day) will reduce the risk of coronary heart disease death, non-fatal myocardial infarction, and fatal or non-fatal stroke in elderly men and women with pre-existing vascular disease or with significant risk of developing this condition. RESULTS: In Scotland, Ireland, and the Netherlands, 23,770 individuals were screened, and 5,804 subjects (2,804 men and 3,000 women), aged 70 to 82 years (average 75 years) and with baseline cholesterol 4.0–9.0 mmol/l, were randomised. Randomised subjects had similar distributions with respect to age, blood pressure, and body mass index when compared to the entire group of screenees, but had a higher prevalence of smoking, diabetes, hypertension, and a history of vascular disease. The average total cholesterol level at baseline was 5.4 mmol/l (men) and 6.0 mmol/l (women). CONCLUSIONS: Compared with previous prevention trials of cholesterol-lowering drugs, the PROSPER cohort is significantly older and for the first time includes a majority of women. The study, having achieved its initial goal of recruiting more than 5,500 elderly high-risk men and women, aims to complete all final subject follow-up visits in the first half of 2002 with the main results being available in the fourth quarter of 2002

The cost-effectiveness of a new disease management model for frail elderly living in homes for the elderly, design of a cluster randomized controlled clinical trial

<p>Abstract</p> <p>Background</p> <p>The objective of this article is to describe the design of a study to evaluate the clinical and economic effects of a Disease Management model on functional health, quality of care and quality of life of persons living in homes for the elderly.</p> <p>Methods</p> <p>This study concerns a cluster randomized controlled clinical trial among five intervention homes and five usual care homes in the North-West of the Netherlands with a total of over 500 residents. All persons who are not terminally ill, are able to be interviewed and sign informed consent are included. For cognitively impaired persons family proxies will be approached to provide outcome information. The Disease Management Model consists of several elements: (1) Trained staff carries out a multidimensional assessment of the patients functional health and care needs with the interRAI Long Term Care Facilities instrument (LTCF). Computerization of the LTCF produces immediate identification of problem areas and thereby guides individualized care planning. (2) The assessment outcomes are discussed in a Multidisciplinary Meeting (MM) with the nurse, primary care physician, nursing home physician and Psychotherapist and if necessary other members of the care team. The MM presents individualized care plans to manage or treat modifiable disabilities and risk factors. (3) Consultation by an nursing home physician and psychotherapist is offered to the frailest residents at risk for nursing home admission (according to the interRAI LTCF). Outcome measures are Quality of Care indicators (LTCF based), Quality Adjusted Life Years (Euroqol), Functional health (SF12, COOP-WONCA), Disability (GARS), Patients care satisfaction (QUOTE), hospital and nursing home days and mortality, health care utilization and costs.</p> <p>Discussion</p> <p>This design is unique because no earlier studies were performed to evaluate the effects and costs of this Disease Management Model for disabled persons in homes for the elderly on functional health and quality of care.</p> <p>Trail registration number</p> <p>ISRCTN11076857</p

Association of Mild Anemia with Cognitive, Functional, Mood and Quality of Life Outcomes in the Elderly: The “Health and Anemia” Study

BACKGROUND: In the elderly persons, hemoglobin concentrations slightly below the lower limit of normal are common, but scant evidence is available on their relationship with significant health indicators. The objective of the present study was to cross-sectionally investigate the association of mild grade anemia with cognitive, functional, mood, and quality of life (QoL) variables in community-dwelling elderly persons. METHODS: Among the 4,068 eligible individuals aged 65-84 years, all persons with mild anemia (n = 170) and a randomly selected sample of non-anemic controls (n = 547) were included in the study. Anemia was defined according to World Health Organization (WHO) criteria and mild grade anemia was defined as a hemoglobin concentration between 10.0 and 11.9 g/dL in women and between 10.0 and 12.9 g/dL in men. Cognition and functional status were assessed using measures of selective attention, episodic memory, cognitive flexibility and instrumental and basic activities of daily living. Mood and QoL were evaluated by means of the Geriatric Depression Scale-10, the Short-Form health survey (SF-12), and the Functional Assessment of Cancer Therapy-Anemia. RESULTS: In univariate analyses, mild anemic elderly persons had significantly worse results on almost all cognitive, functional, mood, and QoL measures. In multivariable logistic regressions, after adjustment for a large number of demographic and clinical confounders, mild anemia remained significantly associated with measures of selective attention and disease-specific QoL (all fully adjusted p<.046). When the lower limit of normal hemoglobin concentration according to WHO criteria was raised to define anemia (+0.2 g/dL), differences between mild anemic and non anemic elderly persons tended to increase on almost every variable. CONCLUSIONS: Cross-sectionally, mild grade anemia was independently associated with worse selective attention performance and disease-specific QoL ratings

Performance Studies

PeerReviewe

Hinterlasse keine Spur

Der Nachwelt ein Zeugnis der eigenen Existenz zu übermitteln, ist ein menschliches Bedürfnis. Allerdings haben unsere Hinterlassenschaften in Form von Umweltverschmutzung schon jetzt ein katastrophales Ausmaß erreicht. Deshalb ist es höchste Zeit, sich mit seinem individuellen Anteil daran auseinanderzusetzen, meint Alice Lagaay